$19.31-1.3%Oct 30 close
Figures through September 27, 2026, from the 10-Q filed October 30, 2026
Kenvue sells nonprescription medicines to shoppers through pharmacies and retailers, alongside skin care, mouthwash, baby care and wound-care products.
| Measure | 3 months toSep 27, 2026 | 3 months toSep 28, 2025 | Change |
|---|---|---|---|
| Total Revenue | $3.9B | $3.8B | +3.24% |
| Profit | $430M | $398M | +8.04% |
| Profit per share | $0.22 | $0.21 | +4.76% |
| Free Cash Flow | $620M | $196M | +216.33% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
“We are pleased to have delivered our fourth consecutive quarter of net and organic sales growth, with strong performance in Self Care and Essential Health, along with margin expansion and strong cash generation,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
The quote and the company description come from Kenvue Inc.’s Item 2.02 8-K filed October 30, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Just reported
From Kenvue Inc.'s results release of October 30, 2026; its quarterly report has since been filed.
Actual
$3.89B
+3.2% y/y
-1.7% q/q
Guided
—
No guide given
Actual
$0.22
+4.8% y/y
-8.3% q/q
Guided
—
No guide given
Actual
$706M
+12% y/y
+1.0% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
A short summary of each call — what the quarter showed, what management expects and whether they delivered on what they said last time — with the full transcript underneath.
Source: Yahoo Finance, transcribed by Quartr. Speaker names and roles are as transcribed; analysts are sometimes unnamed.
Summaries of earlier calls are part of Pro.
Call summaries are part of Pro
A two-minute read of every Kenvue Inc. earnings call: the numbers that mattered, what management expects, whether they delivered on last quarter’s outlook, and what analysts asked that went unanswered.
See one first on , , , or — open to everyone.